South Korea reported 71,476 new COVID-19 cases as of midnight Monday compared with 24 hours ago, bringing the total number of infections to 27,031,319, health authorities said Tuesday.
The number of daily cases rose from 22,327 a day earlier, but was lower than the 72,860 counted a week earlier, according to the Korea Disease Control and Prevention Agency (KDCA).
Over the past week, the daily average of new cases was 53,815.
Among the new cases, 84 were imported from abroad, bringing the total to 71,384.
The number of infected people who were in critical condition stood at 491, unchanged from the previous day.
A further 41 deaths were confirmed, bringing the death toll to 30,454. ■
- South Korea reported 22,327 new cases of COVID-19 as of midnight Sunday, bringing the total number of infections to 26,959,843, health authorities said Monday.
The number of daily cases was lower than the 47,028 the day before and the 23,077 recorded a week earlier, according to the Korea Disease Control and Prevention Agency (KDCA).
Over the last week, the daily average of new cases was 54,012.
Among the new cases, 53 were imported from abroad, bringing the total to 71,300.
The number of infected people who are in critical condition stands at 491, 10 more than the previous day.
Forty-four more deaths were confirmed, bringing the death toll to 30,413. ■
Seoul, May 5, 2022 New cases of COVID-19 in South Korea remained below 50,000 on Thursday for the second day in a row, amid the recent lifting of the outdoor mask mandate in one step important towards the return to normality.
The country had reported 42,296 new COVID-19 infections, bringing the total number of cases to 17,438,068, according to the Korea Disease Control and Prevention Agency (KDCA).
Thursday's tally was slightly lower than the 49,064 reported on Wednesday and well below the 57,464 previously reported a week ago.
Daily coronavirus infections had been trending down in recent weeks after peaking at 621,171 on March 17.
The country added 79 COVID-19 deaths on Thursday, bringing the total to 23,158, the KDCA said, the fatality rate remaining at 0.13 percent.
The number of critically ill patients reached 441, up slightly from 432 the day before.
Of the locally transmitted infections, 6,645 cases were reported in Seoul and 10,242 in the surrounding Gyeonggi province, the KDCA said.
As of midnight Wednesday, 44.55 million people, or 86.8% of the population, had been vaccinated with the first two shots, and 33.16 million people had received the first booster shots, representing 64.6%.
As of May 5, the government lifted the outdoor mask mandate after more than 18 months of compliance, except for large gatherings of 50 or more.
The government had already removed limits on private gatherings and curfews on working hours. (
President Moon Jae-in received his first dose of AstraZeneca’s COVID-19 vaccine on Tuesday, as he plans to attend a Group of Seven (G-7) summit to be held in Britain.
He received the shot at the Jongno-gu public health centre near the presidential compound in Seoul, along with first lady Kim Jung-sook and nine Cheong Wa Dae officials to accompany them on a trip to Britain in June.
The G-7 session is scheduled to take place in the seaside resort of Carbis Bay in Cornwall from June 11 to 13.
Moon arrived at the facility at 9 a.m. and soon got his temperature, identity and health conditions checked.
“Since you are good at giving a shot, it does not hurt at all,” Moon said, while receiving it.
South Korea began the AstraZeneca vaccination programme for those aged 65 and older on Tuesday following a delay attributable to concerns about its safety.
Local health authorities stated the previous day that they had found no evidence suggesting a correlation between the vaccine and reports of blood clots.
The Korea Disease Control and Prevention Agency (KDCA) have drawn up a priority list of vaccine takers.
It allowed an exception for Moon, 68; the 66-year-old first lady; and the Cheong Wa Dae officials, including Suh Hoon, director of national security, for the early inoculation in consideration of diplomacy-related urgency.
The AstraZeneca vaccine required two shots with an interval of eight to 12 weeks.
The KDCA set the health centre as the venue for the president’s vaccination. (Yonhap/NAN)(NAN)
Malaysia approves use of South Korean flu vaccines after temporary suspension
Kuala Lumpur, Nov. 3, 2020 Malaysia has approved the use of two South Korean flu vaccines after a temporary ban following a safety assessment, the country’s Health Ministry said on Tuesday.
The Health Ministry Director-General, Noor Abdullah, said this in a statement in Kuala Lumpur.
Taking into account information from the Korean Disease Control and Prevention Agency (KDCA), safety reports and information from international regulatory bodies, the Malaysian National Pharmaceutical Regulatory Agency cleared the use of the products, Abdullah said.
“The KDCA has confirmed that such occurrences are very low, to be connected to influenza vaccines as the cause of death as reported,” he said.
“KDCA also confirms that no particular brand, manufacturer or batch of vaccines has been connected with any of the deaths.”
He added that 1.5 million doses of South Korean vaccines have been imported into Malaysia as of October and no deaths have been reported as a result of any flu vaccine in the country.
Malaysia in October announced a temporary suspension of the use of two influenza vaccines, namely SKYCellflu Quadrivalent and VaxigripTetra as a precautionary measure after a number of deaths following flu shots in South Korea.
South Korea’s health authorities decided on Oct. 26 to continue the flu vaccination programme across the country as the suspected deaths after getting flu shots were found to have very little link to inoculation.
The KDCA said there was a very little possibility for any link between flu vaccination and deaths, noting that it will continue its nationwide flu vaccination programme.
The programme came as a part of efforts to prevent the so-called “twindemic” of COVID-19 and flu during the winter influenza season.
Edited By: Fatima Sule/Ali Baba-Inuwa
Health authorities in South Korea said on Thursday that the country would resume offering free seasonal flu shots in phases, a month after suspending the programme amid safety concerns over mishandled vaccines during storage.
According to the Korea Disease Control and Prevention Agency (KDCA), the nationwide free flu shot scheme would restart on Tuesday.
KDCA said the vaccines would be administered first to those in the ages between 13 and 18 and would also be given to elderly citizens until the end of the year.
The programme was halted on Sept. 22, after some of the inactivated vaccines were exposed to room temperatures during shipping.
However, the agency said the subsequent quality tests and inspections on the vaccines found no safety problems.
Despite the test results, the agency decided to collect 480,000 doses that could have low potency as part of precautionary measures.
In order to prevent any recurrences, KDCA vowed to strengthen the monitoring of the vaccine distribution process.
South Korea government has provided free flu shots to prevent a potential “twindemic” during winter, as respiratory viruses, including influenza and COVID-19, have nearly identical symptoms, including fever and sore throat.
Edited By: Hadiza Mohammed/Emmanuel Yashim)